Title: | TIE2 mutations in VM : Venous Malformation: from causative TIE2 mutations to murine model and targeted therapy
![]() |
keywords: |
Other
|
ID: |
PRJEB9698
|
description: |
Background: Venous malformations (VM) are composed of ectatic veins with scarce smooth muscle cell coverage. Activating mutations in the endothelial cell tyrosine kinase receptor TIE2 are a common cause of the lesions. VMs expand causing deformity, pain, and local intravascular coagulopathy. Despite sclerotherapy or excision, lesions often recur. Targeted pharmacological therapies are not available. Methods: To generate a model of VM, we injected, in mouse, human umbilical vein endothelial cells (HUVECs) expressing TIE2-L914F, the most frequent VM-causative TIE2 mutation. We tested rapamycin and a TIE2 tyrosine kinase inhibitor (TIE2-TKI), in vivo, for effects on murine VM expansion, and in vitro, for the ability to inhibit mutant-TIE2 signaling. A prospective clinical pilot study analyzed the effects of rapamycin in six patients with difficult–to-treat venous anomalies. Results: HUVECs expressing TIE2-L914F formed VMs with ectatic blood-filled channels. In this VM model, rapamycin prevented lesion growth and, in vitro, effectively reduced mutant-TIE2-induced AKT signaling. TIE2-TKI, developed to target the wildtype receptor, displayed weaker suppression of TIE2 and AKT signaling in HUVECTIE2-L914F. In patients, rapamycin treatment reduced pain, bleeding, lesion size, functional and esthetic impairment, and intravascular coagulopathy. Conclusions: Endothelial cells with TIE2-L914F recapitulated VM in mice. Rapamycin halted lesion expansion by targeting activated AKT signaling downstream of the mutant-TIE2. In patients with difficult-to-treat VMs, rapamycin induced important clinical improvement.
|
accesstypes: |
download
|
landingpage: | http://www.ncbi.nlm.nih.gov/bioproject/PRJEB9698 |
authentication: |
none
|
authorization: |
none
|
dateReleased: |
12-31-2015
|
abbreviation: |
NCBI
|
homePage: | http://www.ncbi.nlm.nih.gov |
ID: |
SCR:006472
|
name: |
National Center for Biotechnology Information
|
homePage: | http://www.ncbi.nlm.nih.gov/bioproject |
ID: |
SCR:004801
|
name: |
NCBI BioProject
|
Expression data: Venous malformation-causative TIE2-mutations mediate an AK...
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitati...
Comparative Genomic Hybridization: genomic control vs. Multiple sclerosis (...
BET Bromodomain Protein BRD4 Regulates MEK Inhibitor-induced Kinome Reprogr...